H S Hwang - Concepedia

Author

H S Hwang

Also Known As

H S Hwang, Hwa-shin Hwang

Publications

342

Citations

H-Index

Concepts

All Affiliations

H S Hwang is an author at Case Western Reserve University specializing in medicine, radiation oncology, and tumor biology.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	336
2	Cell Biology	3	3	311
3	Molecular Biology	2	2	270
4	Natural Sciences	1	1	229
5	Immunology	1	1	41

H S Hwang

Publications

336

Citations

H-Index

Page 1

	Year	Citations
Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses. Mark Meyers, Mark W. Wagner, H S Hwang, PubMed Cell Cycle ResponsesApoptosisMmr DeficienciesCell DeathMolecular Biology	2001	229
Radiosensitivity of thymidylate synthase-deficient human tumor cells is affected by progression through the G1 restriction point into S-phase: implications for fluoropyrimidine radiosensitization. H S Hwang, Thomas W. Davis, Janet A. Houghton, PubMed Radiation EffectRadiation ExposureCell DeathMolecular BiologyCell Cycle	2000	41
Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine. S E Berry, Thomas W. Davis, Jane E. Schupp, PubMed Genome InstabilityDrug-resistant Muts Homologue-2Oncogenic AgentMedicineRadiation Effect	2000	41
Preclinical study of the systemic toxicity and pharmacokinetics of 5-iodo-2-deoxypyrimidinone-2'-deoxyribose as a radiosensitizing prodrug in two, non-rodent animal species: implications for phase I study design. T J Kinsella, Jane E. Schupp, Thomas W. Davis, PubMed Non-rodent Animal SpeciesHigh IpdrPharmacological StudyMedicinePreclinical Study	2000	25

Page 1